文献速递糖尿病性腺与生殖内分泌

妊娠期糖耐量异常与未来糖尿病风险

Gestational Glucose Intolerance and Risk of Future Diabetes.
PubMed 文献 · Diabetes Care · 2023-01-01

该回顾性队列研究纳入16,836名个体的20,359次妊娠,比较妊娠期糖耐量异常(GGI)与正常糖耐量者的糖尿病发病风险。中位随访8.4年,GGI者糖尿病风险较正常糖耐量者升高(aHR 2.01,95%CI 1.54-2.62,P<0.001),且风险随OGTT异常值数目增加而升高。作者认为常规临床数据可识别出可能受益于强化糖尿病筛查和预防的未被识别群体。

要点

  • GGI者未来糖尿病风险较正常糖耐量者升高,aHR 2.01(95%CI 1.54-2.62,P<0.001)。
  • 糖尿病风险随OGTT异常值数目增加而升高,GDM者aHR 8.26(95%CI 6.49-10.51,P<0.001)。
  • 产后10年糖尿病病例中归因于GGI和GDM的比例分别为8.5%和28.1%。

核心结论

  • GGI与未来糖尿病风险升高相关,常规临床数据可识别出可能受益于强化糖尿病筛查和预防的未被识别群体。

研究设计与样本

  • 回顾性队列研究,随访产前和初级保健,纳入16,836名个体的20,359次妊娠。

主要发现

  • 中位随访8.4年,428名个体发生糖尿病;GGI者较正常糖耐量者糖尿病风险升高(aHR 2.01,95%CI 1.54-2.62,P<0.001)。
  • OGTT异常值数目为0个者aHR 1.54(95%CI 1.09-2.16,P=0.01),1个者aHR 2.97(95%CI 2.07-4.27,P<0.001),GDM者aHR 8.26(95%CI 6.49-10.51,P<0.001),均以正常糖耐量者为参照。
  • 产后10年糖尿病病例中归因于GGI和GDM的比例分别为8.5%和28.1%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Pregnant individuals are universally screened for gestational diabetes mellitus (GDM). Gestational glucose intolerance (GGI) (an abnormal initial GDM screening test without a GDM diagnosis) is not a recognized diabetes risk factor. We tested for an association between GGI and diabetes after pregnancy. RESEARCH DESIGN AND METHODS: We conducted a retrospective cohort study of individuals followed for prenatal and primary care. We defined GGI as an abnormal screening glucose-loading test result at ≥24 weeks' gestation with an oral glucose tolerance test (OGTT) that did not meet GDM criteria. The primary outcome was incident diabetes. We used Cox proportional hazards models with time-varying exposures and covariates to compare incident diabetes risk in individuals with GGI and normal glucose tolerance. RESULTS: Among 16,836 individuals, there were 20,359 pregnancies with normal glucose tolerance, 2,943 with GGI, and 909 with GDM. Over a median of 8.4 years of follow-up, 428 individuals developed diabetes. Individuals with GGI had increased diabetes risk compared to those with normal glucose tolerance in pregnancy (adjusted hazard ratio [aHR] 2.01 [95% CI 1.54-2.62], P < 0.001). Diabetes risk increased with the number of abnormal OGTT values (zero, aHR 1.54 [1.09-2.16], P = 0.01; one, aHR 2.97 [2.07-4.27], P < 0.001; GDM, aHR 8.26 [6.49-10.51], P < 0.001 for each compared with normal glucose tolerance). The fraction of cases of diabetes 10 years after delivery attributable to GGI and GDM was 8.5% and 28.1%, respectively. CONCLUSIONS: GGI confers an increased risk of future diabetes. Routinely available clinical data identify an unrecognized group who may benefit from enhanced diabetes screening and prevention.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Selen DJ, Thaweethai T, Schulte CCM, et al. Gestational Glucose Intolerance and Risk of Future Diabetes. Diabetes Care. 2023. PMID: 36473077. doi:10.2337/dc22-1390

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。